Home

Co-Diagnostics, Inc. (CODX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Co-Diagnostics, Inc. (CODX)

Go deeper and ask any question about CODX

Company Performance

Current Price

as of Sep 13, 2024

$1.31

P/E Ratio

N/A

Market Cap

$41.8M

Description

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Metrics

Overview

  • HQSalt Lake City, UT
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerCODX
  • Price$1.31+1.55%

Trading Information

  • Market Cap$41.80M
  • Float94.60%
  • Average Daily Volume (1m)615,211
  • Average Daily Volume (3m)262,265
  • EPS-$1.24

Company

  • Revenue$6.43M
  • Rev Growth (1yr)-18.56%
  • Net Income-$7.60M
  • Gross Margin-241.70%
  • EBITDA Margin-6,106.29%
  • EBITDA-$9.84M
  • EV-$4.64M
  • EV/Revenue-0.72
  • P/EN/A
  • P/S6.14
Documents